Contracts › 75N93025C00025
75N93025C00025: To Develop an Integrated Diagnostic Platform That Utilizes Whole Genome Sequencing (WGS) to Identify Bacterial Pathogens and Predict Antibiotic Susceptibility Directly From Blood, Within a Few Hours - Addressing Limitations With Current Culture-Based
Awarded to Genomic Labs Ltd by National Institutes of Health (NIH).
$1.0Mobligated
$3.5Mpotential value
28 October 2026current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93025C00025 |
|---|---|
| Awardee | Genomic Labs Ltd |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Offers received | 41 |
| Period of performance | 29 September 2025 to 28 October 2026 |
| Potential end | 28 October 2026 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record